| GTO ID | GTC3503 |
| Trial ID | NCT05934838 |
| Disease | Follicular Lymphoma | B-Cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Co-treatment | Tazemetostat |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas |
| Year | 2023 |
| Country | United States |
| Company sponsor | Weill Medical College of Cornell University |
| Other ID(s) | 22-07025095 |
| Cohort 1 | |||||||
|
|||||||